Nova Scotia's lung screening program is still in its infancy, but those leading the effort say they've already been able to ...
Nova Scotia will be the first site in the world to test a potentially groundbreaking cancer treatment. Global pharmaceutical ...
MONTREAL, Feb. 3, 2025 /CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, effective February 1, 2025, Nova Scotia is publicly funding Pluvicto™ (lutetium (177Lu) ...
The purpose of this study was to examine colorectal cancer (CRC) follow-up care in Nova Scotia, Canada. More specifically, the objectives were to describe adherence to two elements of follow-up ...
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lung Cancer: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results